BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 20814411)

  • 21. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
    Sommer M; Wolf G
    Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docosahexaenoic acid regulates adipogenic genes in myoblasts via porcine peroxisome proliferator-activated receptor gamma.
    Yu YH; Lin EC; Wu SC; Cheng WT; Mersmann HJ; Wang PH; Ding ST
    J Anim Sci; 2008 Dec; 86(12):3385-92. PubMed ID: 18676720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of low-dose docosahexaenoic acid and eicosapentaenoic acid on the regulation of mitogenic signaling pathways in mesangial cells.
    Yusufi AN; Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Grande JP
    J Lab Clin Med; 2003 May; 141(5):318-29. PubMed ID: 12761475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
    Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.
    Walker GE; Marzullo P; Verti B; Guzzaloni G; Maestrini S; Zurleni F; Liuzzi A; Di Blasio AM
    Obesity (Silver Spring); 2008 Sep; 16(9):1983-91. PubMed ID: 19186324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase.
    Liu G; Grifman M; Macdonald J; Moller P; Wong-Staal F; Li QX
    J Endocrinol; 2007 Sep; 194(3):569-78. PubMed ID: 17761896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of eicosapentaenoic acid and docosahexaenoic acid on expression of genes connected with metabolism and secretory functions of ageing 3T3-L1 adipocytes.
    Prostek A; Gajewska M; Bałasińska B
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():48-56. PubMed ID: 27166928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects.
    Kim MK; Chae YN; Choi SH; Moon HS; Son MH; Bae MH; Choi HH; Hur Y; Kim E; Park YH; Park CS; Kim JG; Lim JI; Shin CY
    Eur J Pharmacol; 2011 Jan; 650(2-3):673-81. PubMed ID: 20974124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of eicosapentaenoic acid and docosahexaenoic acid in promoting the differentiation of 3T3-L1 preadipocytes.
    Murali G; Desouza CV; Clevenger ME; Ramalingam R; Saraswathi V
    Prostaglandins Leukot Essent Fatty Acids; 2014 Jan; 90(1):13-21. PubMed ID: 24332315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DHA increases adiponectin expression more effectively than EPA at relative low concentrations by regulating PPARγ and its phosphorylation at Ser273 in 3T3-L1 adipocytes.
    Song J; Li C; Lv Y; Zhang Y; Amakye WK; Mao L
    Nutr Metab (Lond); 2017; 14():52. PubMed ID: 28811832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of EPA and DHA on markers of inflammation in 3T3-L1 cells at different stages of cellular maturation.
    Prostek A; Gajewska M; Kamola D; Bałasińska B
    Lipids Health Dis; 2014 Jan; 13():3. PubMed ID: 24387137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation.
    Marion-Letellier R; Butler M; Déchelotte P; Playford RJ; Ghosh S
    Am J Clin Nutr; 2008 Apr; 87(4):939-48. PubMed ID: 18400717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Docosahexaenoic acid decreases pro-inflammatory mediators in an in vitro murine adipocyte macrophage co-culture model.
    De Boer AA; Monk JM; Robinson LE
    PLoS One; 2014; 9(1):e85037. PubMed ID: 24465472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium.
    Xue H; Wan M; Song D; Li Y; Li J
    Vascul Pharmacol; 2006 Jun; 44(6):434-9. PubMed ID: 16616699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
    Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eicosapentaenoic acid and docosahexaenoic acid synergistically attenuate bile acid-induced hepatocellular apoptosis.
    Tillman EM; Helms RA; Black DD
    JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1):36-42. PubMed ID: 22038211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation.
    Berge RK; Madsen L; Vaagenes H; Tronstad KJ; Göttlicher M; Rustan AC
    Biochem J; 1999 Oct; 343 Pt 1(Pt 1):191-7. PubMed ID: 10493929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
    Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
    Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.